Published in Vaccine Weekly, July 14th, 1997
Expanding on previous research, Bert W. O'Malley Jr. and colleagues from Johns Hopkins University, Maryland; the Baylor College of Medicine, Texas; and Osaka University Medical Center, Japan, investigated the immunological role IL-2 plays in single or combination gene therapy and provided insight into the limitations of adenoviral-mediated cytokine delivery to head and neck cancer ("The Role of Interleukin-2 in Combination Adenovirus Gene Therapy for Head and Neck...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly